The Carroll lab is interested in understanding how Estrogen Receptor (ER) causes gene transcription and how this contributes to breast cancer progression. We are also interested in understanding how breast cancer therapies work and what happens if they fail. We explore this using molecular, genomic and proteomic approaches, with the goal of identifying the critical determinants of tumour progression so that we can develop novel therapies that specifically target them.


The lab is currently looking to recruit a PhD student to study the relationship among the transcription factors ER and FOXA1, and drug resistence in breast cancer.

+44 (0) 1223 769 666

(c) Carroll Lab

Website design by, site development by Intelligent Penguin

The Carroll Lab is a part of Cancer Research UK and is based at Cambridge Research Institute, Robinson Way, Cambridge, CB2 0RE, United Kingdom. All information on this website is copyright to Jason Carroll unless otherwise stated.